A Study to Evaluate the Effect of SAR443820 on Serum Neurofilament Levels in Male and Female Adult Participants With Multiple Sclerosis
Stopped The study was terminated as it did not meet its primary and key secondary endpoints
Conditions
Interventions
- DRUG: SAR443820
- OTHER: Placebo
Sponsor
Sanofi